Blood Cancer 101: The Basics on Disease, Treatment, and the Role of the HCP
Webcasts y Videos en Español
Applying Genomics and Biomarker Testing in Caring for Patients with Blood Cancer: A Primer for Healthcare Providers
Description
Precision medicine is an emerging approach for prediction of disease risk and disease treatment afforded by the delivery of more precise and efficient care. This approach combines traditional methods with genetic and genomic information for a more personalized approach to disease management. This video will help clinicians become familiar with foundational genomic information to take part in the integration of biomarker testing for precise diagnosis, assessing targeted therapeutic options, and avoidance of adverse reactions when treating patients with blood cancer.
Staying Connected®: Facilitating the Learning Experience During & After Cancer Treatment
Online course for school personnel and healthcare providers who support students who have survived or are being treated for any type of cancer. Interactive modules focus on treatment and side effects, education, and psychosocial challenges, coping with grief, and provide strategies and resources for professionals and the children and young adults they serve.
This free 6.5 hour online continuing education (CE) course is designed to be completed at a time that is convenient to you – following registration, you will have up to 16 weeks to complete the course in its entirety and receive CE credit or up to 3 weeks for the non-accredited track.
An email confirmation and course access information will be sent to you within 30 minutes of your registration.
The Blood Cancer United Scholarship for Blood Cancer Survivors awards up to $7,500 towards tuition for virtual or in-person vocational, two- or four-year undergraduate education.
CE credit available until: October 30, 2025
Additional Resources
Videos:
- Click here to watch a classroom presentation on how to talk to children about their classmate with cancer.
- Click here to watch a panel discussion for practical tips on transitioning your student back to school.
Podcast Episode: Click here to listen to Facilitating the Learning Experience of Children & AYA’s During and After Cancer Treatment.
Children's Book Series and Movie: Stars Will Twinkle, The Sun Will Shine is a three-book series and movie for kids with blood cancer. Follow Olivia and her family as she is diagnosed with leukemia, goes to the hospital for treatment, and returns to school.
Download files:
The differences between IEPs and 504 plans (PDF)
Download Helpful Resources (PDF)
Target Audience
School nurses, social workers, teachers, school counselors and other school and college personnel. Parents are welcome.
Learning level: All levels
Goal
To educate school and college personnel on the effects of childhood, adolescent and young adult cancer treatment to improve the learning experience during and after cancer treatment.
Learning Objectives
At the conclusion of this course, participants will be able to:
- Identify cancers that affect children, adolescents, and young adults (AYAs)
- Identify side effects, long-term and late effects of childhood/AYA cancer treatment
- Describe challenges for survivors throughout their education
- Explain laws that protect childhood/AYA cancer survivors’ rights
- Develop strategies to help meet the students’ short- and long-term education needs
- Discuss how to prepare the student body and faculty when a student is undergoing cancer treatment
- Explain how to prepare students and faculty for the impending death of a student
- List strategies to support healing for students and faculty prior to and after the death of a student
- Access resources that support schools and families, including those from The Leukemia & Lymphoma Society
Modules
- Introduction to Staying Connected®: Facilitating the Learning Experience During and After Cancer Treatment
- Treatment and Side Effects of Childhood, Adolescent, and Young Adult (AYA) Cancers
Cancers diagnosed in children, adolescents, and young adults (AYA), and common symptoms, treatment options, and side effects of treatment. - Psychosocial Concerns of a Cancer Diagnosis in Children, Adolescents, and Young Adults (AYA )
Psychosocial impact of a cancer diagnosis on the patient, their family and peers, and age appropriate information and strategies to help the student and their peers. - The Education Journey During and After Cancer Treatment: Approaches to Dealing with These Challenges
Challenges survivors face throughout their education journey, strategies to help meet the students’ short- and long-term education needs, and laws that protect pediatric cancer survivors’ education rights. - Coping with Grief, Loss, and Bereavement throughout the Treatment Continuum
Impact of grief and loss and strategies to help school personnel, peers, and families cope with their grief
Continuing Education Information
Staying Connected® Modules 1 – 4: Medical, Psychosocial, Education
- Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 5.5 continuing education contact hours through the California Board of Registered Nursing. - Social Work Credit Designation
The Leukemia & Lymphoma Society (LLS), Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) course. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 5.5 clinical continuing education credits.
LLS is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #SW- 0117. LLS maintains responsibility for the course. Social workers will receive 5.5 clinical CE contact hours for this activity. - Education
Teachers, school counselors, and other school and college personnel will receive a Certificate of Completion to submit to their local professional development approval committee. Prior approval for acceptance of this training may be required.
Staying Connected® Module 5: Grief
- Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hours through the California Board of Registered Nursing. - Social Work Credit Designation
The Leukemia & Lymphoma Society (LLS), Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) course. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.0 clinical continuing education credit.
LLS is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #SW- 0117. LLS maintains responsibility for the course. Social workers will receive 1.0 clinical CE contact hours for this activity. - Education
Teachers, school counselors, and other school and college personnel will receive a Certificate of Completion to submit to their local professional development approval committee. Prior approval for acceptance of this training may be required
Provider
This course is provided by The Leukemia & Lymphoma Society.
Sponsors and Supporters
This course is supported in part by The John and Frances Beck Family Foundation Fund at The Pittsburgh Foundation, and an educational grant from the Allegheny Foundation.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: [email protected].
Hematology Horizons Vlog Series
This video series brings you onsite to learn about the latest advances in blood cancer treatment and navigating survivorship.
A video series that brings you onsite to learn about the latest advances in blood cancer treatment and navigating survivorship.
We hope you find this vlog informative and helpful. We would really appreciate your feedback, which helps us to plan future episodes and resources.
Body Image After Cancer: Tips, Tools and Mindset Shifts
Join Elissa Baldwin from the LLS Patient Education team for this episode filmed onsite at the Association of Oncology Social Work annual meeting in Atlanta, GA. In this interactive conversation, oncology social worker Carrie Panzer, LCSW, explores how body image can shift after a cancer diagnosis—and how patients and survivors can use simple, powerful mindset tools to navigate these changes. Exploring the principles of Acceptance and Commitment Therapy (ACT), this episode invites you to grab a pen and paper and participate in real time, learning techniques like “thought defusion” and gratitude practices that can help ease the emotional impact of body changes.
This episode was supported by Genentech, a member of the Roche Group.
Managing AML in Community Clinics
Join Elissa Baldwin from the LLS Patient Education team as she visits with Dr. Luke Fletcher from Willamette Valley Cancer Institute in Eugene, OR. In this episode, Dr. Fletcher discusses how acute myeloid leukemia (AML) is treated in a community oncology clinic, highlighting the importance of local care for patients who may not live close to major cancer centers. He also shares insights into the latest treatment advances, including menin inhibitors and novel combination therapies that are shaping the future of AML care.
For patients with other blood cancers living in rural or underserved areas, tune in at timestamps 10:18 and 18:11 to learn more about oncology care in the community setting and how local clinics coordinate with larger cancer centers to support comprehensive treatment.
This episode was supported by Abbvie Inc.
Personalizing My Myeloma Treatment
Join Elissa Baldwin from the LLS Patient Education team as she takes you onsite at the Summit on Hematologic Cancers conference presented by the Binaytara Foundation. In this episode, Dr. Sagar Lonial from the Winship Cancer Institute of Emory University in Atlanta, GA, shares how doctors are tailoring myeloma treatments to improve outcomes and provide hope for myeloma patients and their families.
Supported by Genentech, A Member of the Roche Group
Highlights in Blood Cancer Research
Join Elissa Baldwin of the LLS Patient Education team as she takes you onsite to the American Society of Hematology (ASH) Annual Meeting to hear about the latest advances in blood cancer research. In this episode, we will hear from leading oncology experts about CAR T-cell therapy, pediatric acute lymphoblastic leukemia (02:13), chronic myeloid leukemia (05:02), acute myeloid leukemia (08:26), non-Hodgkin lymphoma (10:32), myeloproliferative neoplasms (13:20), and multiple myeloma (16:21). (If you hover over the progress bar while watching the video, you will see these timestamps.)
This episode is NOT an official program of the ASH annual meeting.
Supported by Amgen, Inc.
Please note: More information from the ASH annual meeting is coming in mid-January at LLS.org/Blog.
Transitioning to Primary Care
Join Elissa Baldwin of the LLS Patient Education team as she takes you onsite to CancerCon®, a young adult cancer conference presented by Stupid Cancer®. In this episode, she speaks to Dr. Samantha Siegel, MD of Kaiser Permanente and Donna Bell, MSN, RN, NP-C from MD Anderson Cancer Center about the benefits of being established with a primary care physician for continued survivorship care.
Supported by Genentech, a member of the Roche Group.
Managing Side Effects
Join Elissa Baldwin of the LLS Patient Education team as she speaks to Jeffrey Zonder, MD of Karmanos Cancer Institute in Detroit, MI. In this episode, we discuss the side effects that blood cancer patients may experience during and after treatment. Dr. Zonder expresses the importance of open communication with the treatment team to better manage side effects.
CAR T-Cell Therapy and the Patient Experience
Join Elissa Baldwin of the LLS Patient Education team as she speaks to Olaleken Oluwole, MBBS, MD and Brittney Baer, BSN, RN, of Vanderbilt University Medical Center in Nashville, TN about CAR T-cell therapy. In this episode we discuss this groundbreaking therapy as well as after care for patients.
Supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Johnson & Johnson & Legend Biotech; Kite, a Gilead Company; and Novartis Pharmaceuticals Corp.
A Journey Through the Lab: Advancements in Blood Cancer Testing
Join Elissa Baldwin of the LLS Patient Education team as she speaks to Dr. Stephanie McAlhany of Labcorp Oncology about genomics and genetics testing for blood cancers. Have you ever wondered what happens after a bone marrow biopsy or blood test? Join us on a journey through the testing lab. You will learn about the importance of these tests, and how the results are used to provide you with the most accurate diagnosis and treatment options for your specific blood cancer. Individualized medicine starts here.
Supported by Labcorp Oncology
Adolescent and Young Adult (AYA) Episodes:
Transitions in Cancer Care: The Roadmap of Survivorship
In this episode, you will hear how their presentation addresses how young adults navigate through the various transitions of cancer survivorship. These transitions may include when patients finish treatment, move from pediatric care to adult care, or age out of the AYA (Adolescent and Young Adult) group altogether, and more.
Supported by a grant from Genentech, Inc. & Biogen.
Live from the 5th Annual Global Adolescent and Young Adult (AYA) Global Cancer Congress
Join Elissa Baldwin of the LLS Patient Education team as she speaks to Jim Brewer, Vice President of LLS’s Dare To Dream Project. In this episode, you will hear how LLS’s education programs, individualized support, public policy efforts, and innovative, worldwide PedAL Master Clinical Trial are transforming the landscape of pediatric cancer, resulting in promising therapies and better outcomes for patients.
Spanish Episode:
Trasplantes para Cáncer de Sangre y Enfermedad Injerto Contra Huésped:
En este episodio hablamos con Eneida Nemecek, MD, MS, MBA sobre el trasplante de células madre para los cánceres de sangre. Discutimos cómo los trasplantes son opciones de tratamiento para muchos pacientes con cáncer de sangre. Discutimos cómo funciona el Registro de Donantes para posibles donantes de células madre. También se analiza la enfermedad de injerto contra huésped, un posible efecto secundario del trasplante y cómo se puede controlar.
Transplants for Blood Cancer and Graft Versus Host Disease:
In this episode, we speak with Eneida Nemecek, MD, MS, MBA about stem cell transplantation for blood cancers. We discuss how transplantations are treatment options for many blood cancer patients. We discuss how the Donor Registry works for potential stem cell donors. Also discussed is Graft versus Host disease, a possible side effect from transplant, and how it can be managed.